7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $6.2B | $187M | 53.3% | 0.0% | $538M | $8.6B | $574M |
| 2024 | $6.4B | $864M | 58.0% | 0.0% | $764M | $8.9B | $675M |
| 2023 | $6.3B | $1.0B | 59.8% | 0.0% | $548M | $8.8B | $693M |
| 2022 | $6.2B | $917M | 62.8% | 0.0% | $662M | $8.9B | $706M |
| 2021 | $6.3B | $1.4B | 62.2% | 0.0% | — | $9.1B | $737M |
| 2020 | $6.5B | $2.2B | 67.6% | 0.0% | — | $0 | $12M |
| 2019 | $7.8B | $3.2B | 70.8% | 0.0% | — | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.5B | $146M | 53.6% | 0.0% | $188M | $8.6B | $1.1B |
| Dec '25 | $1.5B | -$205M | 49.2% | 0.0% | $96M | $8.6B | $574M |
| Sep '25 | $1.6B | $160M | 53.5% | 0.0% | $218M | $8.8B | $672M |
| Jun '25 | $1.6B | $145M | 54.8% | 0.0% | $181M | $8.9B | $599M |
| Mar '25 | $1.5B | $87M | 55.6% | 0.0% | $43M | $9.0B | $547M |
| Dec '24 | $1.6B | $109M | 56.3% | 0.0% | $335M | $8.9B | $675M |
| Sep '24 | $1.6B | $359M | 58.3% | 0.0% | $99M | $8.7B | $763M |
| Jun '24 | $1.6B | $195M | 58.4% | 0.0% | $300M | $8.7B | $704M |
| Mar '24 | $1.6B | $201M | 59.0% | 0.0% | $30M | $8.7B | $575M |
| Dec '23 | $1.6B | $546M | 57.3% | 0.0% | $318M | $8.8B | $693M |
| Sep '23 | $1.5B | $58M | 59.7% | 0.0% | $206M | $8.7B | $414M |
| Jun '23 | $1.6B | $242M | 60.2% | 0.0% | -$44M | $8.7B | $326M |
| Mar '23 | $1.5B | $177M | 62.3% | 0.0% | $68M | $8.7B | $459M |
| Dec '22 | $1.5B | $108M | 60.0% | 0.0% | — | $8.9B | $706M |
| Sep '22 | $1.5B | $227M | 64.2% | 0.0% | $262M | $8.7B | $499M |
| Jun '22 | $1.6B | $234M | 62.9% | 0.0% | $106M | $8.9B | $545M |
| Mar '22 | $1.6B | $348M | 64.2% | 0.0% | $90M | $9.1B | $694M |
| Dec '21 | $1.6B | $202M | 62.6% | 0.0% | — | $9.1B | $737M |
| Sep '21 | $1.6B | $323M | 61.9% | 0.0% | — | $9.3B | $1.0B |
| Jun '21 | $1.6B | $427M | 63.4% | 0.0% | — | $9.3B | $730M |
How the market has priced OGN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Organon & Co.'s revenue has declined 1.0% per year, and net income declined 38.7% per year. These are computed facts, not advice.
As of FY2025, Organon & Co. reported $8.6B of total debt against $574M of cash.
In FY2025, gross margin was 53.3%, operating margin —, and net margin 3.0%.
As of Jun '26, Organon & Co. traded at a price-to-earnings ratio of about 18.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.